Volume 21, Issue 3 2408543
Review

Biomimetic Materials for Antibacterial Applications

Junjie Zhang

Junjie Zhang

School of Fundamental Sciences, Bengbu Medical University, Bengbu, 233030 P. R. China

Search for more papers by this author
Heng Dong

Corresponding Author

Heng Dong

Nanjing Stomatological Hospital, Affiliated Hospital of Medical School, Research Institute of Stomatology, Nanjing University, 30 Zhongyang Road, Nanjing, Jiangsu, 210008 P. R. China

E-mail: [email protected]; [email protected]; [email protected]

Search for more papers by this author
Bing Liu

Corresponding Author

Bing Liu

School of Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023 P. R. China

E-mail: [email protected]; [email protected]; [email protected]

Search for more papers by this author
Dongliang Yang

Corresponding Author

Dongliang Yang

Key Laboratory of Flexible Electronics (KLOFE) and Institute of Advanced Materials (IAM), School of Physical and Mathematical Sciences, Nanjing Tech University (NanjingTech), Nanjing, 211816 P. R. China

E-mail: [email protected]; [email protected]; [email protected]

Search for more papers by this author
First published: 22 November 2024
Citations: 2

Abstract

The rise of antibiotic resistance poses a critical threat to global health, necessitating the development of novel antibacterial strategies to mitigate this growing challenge. Biomimetic materials, inspired by natural biological systems, have emerged as a promising solution in this context. These materials, by mimicking biological entities such as plants, animals, cells, viruses, and enzymes, offer innovative approaches to combat bacterial infections effectively. This review delves into the integration of biomimicry with materials science to develop antibacterial agents that are not only effective but also biocompatible and less likely to induce resistance. The study explores the design and function of various biomimetic antibacterial materials, highlighting their therapeutic potential in anti-infection applications. Further, the study provides a comprehensive summary of recent advancements in this field, illustrating how these materials have been engineered to enhance their efficacy and safety. The review also discusses the critical challenges facing the transition of these biomimetic strategies from the laboratory to clinical settings, such as scalability, cost-effectiveness, and long-term stability. Lastly, the study discusses the vast opportunities that biomimetic materials hold for the future of antibacterial therapy, suggesting that continued research and multidisciplinary collaboration will be essential to realize their full potential.

Conflict of Interest

The authors declare no conflict of interest.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.